期刊文献+

Cbl-b基因shRNA干扰载体的构建及鉴定 被引量:3

Construction and identification of a short hairpin RNA expression vector targeting the Cbl-b gene
原文传递
导出
摘要 目的 构建小鼠Cbl-b基因RNA干扰(RNAi)的真核表达质粒,并初步鉴定其干扰效果,为后续研究Cbl-b在黑素瘤免疫治疗中的作用奠定基础.方法 根据基因库提供的Cbl-b cDNA序列,设计并合成4对短发夹结构的互补DNA序列,克隆至载体PGPU6/GFP/Neo构建重组质粒,并予以DNA测序鉴定.重组干扰质粒构建成功后,将干扰质粒与Cbl-b过表达载体共转染293T细胞,于转染后48 h,通过实时荧光定量PCR法及蛋白质印迹法检测各质粒对Cbl-b基因的表达抑制效应.结果 测序分析证实,4对shRNA寡核苷酸序列分别成功插入至shRNA真核表达载体PGPU6/GFP/Neo中,将构建成功的PGPU6/GFP/Neo-shRNA质粒与Cbl-b真核表达载体共转染细胞48 h后,通过荧光实时定量PCR法及Western印迹测定,发现4条shRNA序列对Cbl-b的表达均有一定的抑制效应,其中以1号shRNA序列重组质粒对Cbl-b表达的抑制程度最高(P<0.05).结论 成功构建并筛选出沉默效应最高的Cbl-b shRNA真核细胞表达载体. Objective To construct a eukaryotic expression plasmid vector encoding Cbl-b gene-specific short hairpin RNAs (shRNAs),and to evaluate its interference effect,so as to lay a foundation for further study on the role of Cbl-b in the immunotherapy of malignant melanoma.Methods According to the sequence of Cbl-b cDNA,4 pairs of shRNAs targeting the Cbl-b gene were designed and synthesized,and then inserted into the plasmid PGPU6/GFP/Neo to construct recombinant plasmids.After identification by DNA sequencing,the 4 shRNA expression vectors were cotransfected into 293T cells with the Cbl-b gene eukarytic expresson plasmid,respectively.The knockdown efficiency of these shRNA expression plasmids on Cbl-b expression was evaluated by real-time (RT) fluorescence-based quantitative PCR and Western blot at 48 hours aftert transfection.Results Sequencing analysis revealed that all the 4 pairs of shRNAs were successfully inserted into the eukarytic expression vector PGPU6/GFP/Neo.As RT-PCR and Western blot showed,all the 4 shRNA-expressing vectors could downregulate Cbl-b expession,and the NO.1 shRNA-expressing vector displayed the strongest interference effect(P 〈 0.05).Conclusions A eukaryotic expression plasmid vector was successfully constructed for Cbl-b gene-specific shRNAs,and the most effective shRNA was selected in this study.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2015年第3期204-207,共4页 Chinese Journal of Dermatology
基金 国家自然科学基金面上项目(81171513)
关键词 泛素蛋白连接酶类 RNA 小分子干扰 黑色素瘤 Cbl-b Ubiquitin-protein ligases RNA,small interfering Melanoma Genes,Cbl-b
  • 相关文献

参考文献12

  • 1Heissmeyer V, Macian F, Im SH, et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins [J ]. Nat Immunol, 2004, 5(3 ): 255-265. 被引量:1
  • 2Jeon MS, Atfield A, Venuprasad K, et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell aner induction [J]. Immunity, 2004, 21(2): 167-177. 被引量:1
  • 3Mueller DL. E3 ubiquitin ligases as T cell anerg3-' factors [J]. Nat Immunol, 2004, 5(9): 883-890. 被引量:1
  • 4Paolino M, Penninger JM. E3 ubiquitin ligases in T-cell tolerance [ J ]. Eur J Immunol, 2009, 39( 9 ): 2337-2344. 被引量:1
  • 5Gronski MA, Bouher JM, Moskophidis D, et al. TCR 'affinity and negative regulation limit autoimmunity [J]. Nat Med, 2004, 10 ( 11 ): 1234-1239. 被引量:1
  • 6Baehmaier K, Krawczyk C, Kozieradzki I, et al. Negative regulation of lymphocyte activation and autoimmunity by the molecularadaptor Cbl-b [ J ]. Nature, 2000, 403 (6766): 211-216. 被引量:1
  • 7Chiang YJ, Kole HK, Brown K, et al. Cbl-b regulates the CD28 depen- dence of T-cell activationJ ]. Nature, 2000, 403(6766): 216-220. 被引量:1
  • 8Krawczyk C, Baehmaier K, Sasaki T, et al. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T ceils [J]. Immunity, 2000, 13(4): 463-473. 被引量:1
  • 9Wohlfert EA, Callahan MK, Clark RB. Resistance to CD4+CD25 regulatory T cells and TGF-beta in Cbl-b4- mice [J]. J Immunol, 2004, 173(2): 1059-1065. 被引量:1
  • 10Ortiz-Quintero B. RNA interference: from origins to a novel tool for gene silencing[ J 1. Rev Invest Clin, 2009, 61 (5):412-427. 被引量:1

二级参考文献11

  • 1Davies H,Bignell GR,Cox C,et al.Mutations of the BRAF gene in human cancer.Nature,2002,417:949-954. 被引量:1
  • 2Smalley KS,Herlyn M.Loitering with intent:new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions.J Invest Dermatol,2004,123:xvi-xvii. 被引量:1
  • 3Hannon GJ.RNA interference.Nature,2002,418:244-251. 被引量:1
  • 4Paddison PJ,Caudy AA,Hannon GJ.Stable suppression of gene expression by RNAi in mammalian cells.Proc Natl Acad Sci U S A,2002,99:1443-1448. 被引量:1
  • 5Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells.Science,2002,296:550-553. 被引量:1
  • 6Shi Y.Mammalian RNAi for the masses.Trends Genet,2003,19:9-12. 被引量:1
  • 7Akslen LA,Angelini S,Straume O,et al.BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival.J Invest Dermatol,2005,125:312-317. 被引量:1
  • 8Hoeflich KP,Gray DC,Eby MT,et al.Oncogenic BRAF is required for tumor growth and maintenance in melanoma models.Cancer Res,2006,66:999-1006. 被引量:1
  • 9Sumimoto H,Miyagishi M,Miyoshi H,et al.Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.Oncogene,2004,23:6031-6039. 被引量:1
  • 10Aoyama Y,Avruch J,Zhang XF.Norel inhibits tumor cell growth independent of Ras or the MST1/2 kinases.Oncogene,2004,23:3426-3433. 被引量:1

共引文献6

同被引文献14

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部